Grahame T. Sewell was born in Australia and has joint British and Australian nationality.  He has enjoyed three stages in his career.  His early experience, having qualified as a chartered accountant, was working with Ernst & Young.  Then he moved into industry.  He was CFO for Lotus Development’s International Division, and helped to lead a software business which grew from a complete start-up to become a $250m division in five years.  Then he became CFO of Reebok’s International Division, at the time that Reebok was creating its international distribution structure and enjoyed exponential growth.  Then he joined the board of UniChem plc, one of Europe’s largest pharmaceutical wholesalers with revenues of £1 billion, as they completed an IPO on the London Stock Exchange.  At UniChem he was instrumental in making the first acquisitions in continental Europe and also in building a large retail pharmacy chain through acquisition.

In 1995 Grahame took the decision to set up his own private equity company, GTS Ventures Ltd, which has been active in helping a number of early-stage companies in technology, healthcare and financial services, to build and create shareholder value.  Typically Grahame has joined the boards of these companies, strengthened the boards and management teams, played a key role in raising finance and led the strategy to plan the Exit, through a trade sale or IPO.

During this time, two companies have completed IPOs.  At Synigence plc, as CEO, Grahame led the company through IPO and enabled shareholders to benefit from a ten-fold increase in the share price.  At 1st Dental Laboratories plc, the country’s leading dental laboratory group, where he is the senior Non-Executive Director, the Company has developed from start-up to revenues of £15m.  Through GTS Ventures Ltd, he has also completed five exits through trade sales.

Grahame is currently Chairman or Non-Executive Director of a number of companies, including:

-  GetMeIn Limited, one of Europe’s leading ticketing companies,

-  Credit-IQ Limited, a leader in data-mining within the financial services industry, and

-  1st Dental Laboratories plc.

Grahame is also a Board Observer at BlueSpace Software.  BlueSpace has developed a secure communication system for government and the security industry.  He was CEO until the Company was re-located from the UK to the USA in 2006 to be closer to the target customers.  Grahame and his family live in the UK, just outside of London. As Sage’s London partner, Grahame has a particular interest in assisting UK companies wishing to grow their presence in the US, and working with US companies wishing to gain entry into the UK or European marketplace.